interferon-alpha plasmid transgene therapy (ZIOPHARM/Intrexon)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterferon-alpha plasmid transgene therapy (ZIOPHARM/Intrexon)
Drug Alias NamepRTS-IFNalpha
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionInterferon alpha modulators
TargetsInterferon alpha
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlaunos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlaunos Therapeutics IncPrecigen Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A